Saxena Nishant C

Chief Business OfficerCorbus Pharmaceuticals Holdings, Inc. (CRBP) · full profile →Form 4 · filed Jun 3, 2026
Net Buying
Open-Market Buys
$101K
Open-Market Sells
$0
Net Open-Market Flow
$101K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 3, 2026Buy(P)9K$7.58$68K75K
Jun 2, 2026Buy(P)5K$7.33$33K66K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-255834) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about CRBP insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001193125-26-255834"
Ask your agent
Use Arkolith to summarize insider buying and selling at Corbus Pharmaceuticals Holdings, Inc.
over the last 90 days and cite the filings.